Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Gebski

Showing results (81-90 of 248) with videos related to

Pageof 25
Sort By:
Gynecologic Oncology|October 4, 2006
Thromboembolic complications in patients with clear cell carcinoma of the ovaryYusuke Matsuura, Greg Robertson, Donald E Marsden, et al.
Acta Oncologica (Stockholm, Sweden)|July 30, 2015
Volumetric and dosimetric changes to salivary glands during radiotherapy for head and neck cancerMaria Najim, Lakmalie Perera, Louise Bendall, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 19, 2015
Prehospital response model and time to CT scan in blunt trauma patients; an exploratory analysis of data from the head injury retrieval trialAlan A Garner, Kristy P Mann, Elwyn Poynter, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 18, 2007
Influence of the way results are presented on research interpretation and medical decision making: the PRIMER collaboration randomized studiesThomas Philip Shakespeare, Val Gebski, Johann Tang, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 22, 2009
Uterine papillary serous carcinoma: patterns of failure and survivalWei Wang, Viet DO, Russell Hogg, et al.
BMC Cancer|December 10, 2014
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX studyPeter Gibbs, Val Gebski, Mark Van Buskirk, et al.
Asia-Pacific Journal of Clinical Oncology|January 17, 2018
Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastomaEugene Wong, Najmun Nahar, Eric Hau, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2021
Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reportingKatherine E Francis, Val Gebski, Sarah J Lord, et al.
Asia Pacific Journal of Clinical Nutrition|March 1, 2005
The effects of iodine on intelligence in children: a meta-analysis of studies conducted in ChinaMing Qian, Dong Wang, William E Watkins, et al.
JMIR Research Protocols|February 17, 2017
VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB TrialsVal Gebski, Emma Gibbs, Mihir Gandhi, et al.
Pageof 25

Showing results (81-90 of 248) with videos related to

Sort By:
Pageof 25
Gynecologic Oncology|October 4, 2006
Thromboembolic complications in patients with clear cell carcinoma of the ovaryYusuke Matsuura, Greg Robertson, Donald E Marsden, et al.
Acta Oncologica (Stockholm, Sweden)|July 30, 2015
Volumetric and dosimetric changes to salivary glands during radiotherapy for head and neck cancerMaria Najim, Lakmalie Perera, Louise Bendall, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 19, 2015
Prehospital response model and time to CT scan in blunt trauma patients; an exploratory analysis of data from the head injury retrieval trialAlan A Garner, Kristy P Mann, Elwyn Poynter, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 18, 2007
Influence of the way results are presented on research interpretation and medical decision making: the PRIMER collaboration randomized studiesThomas Philip Shakespeare, Val Gebski, Johann Tang, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 22, 2009
Uterine papillary serous carcinoma: patterns of failure and survivalWei Wang, Viet DO, Russell Hogg, et al.
BMC Cancer|December 10, 2014
Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX studyPeter Gibbs, Val Gebski, Mark Van Buskirk, et al.
Asia-Pacific Journal of Clinical Oncology|January 17, 2018
Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastomaEugene Wong, Najmun Nahar, Eric Hau, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2021
Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reportingKatherine E Francis, Val Gebski, Sarah J Lord, et al.
Asia Pacific Journal of Clinical Nutrition|March 1, 2005
The effects of iodine on intelligence in children: a meta-analysis of studies conducted in ChinaMing Qian, Dong Wang, William E Watkins, et al.
JMIR Research Protocols|February 17, 2017
VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB TrialsVal Gebski, Emma Gibbs, Mihir Gandhi, et al.
Pageof 25